Life science businesses from across the Midlands came together on 24 May to hear about the latest support provided by Medilink Midlands.

The launch event on 24 May offered an insight into what the new ‘MeTAP’ sector focused business support programme can offer. Open to companies in the Nottingham City Council region, MeTAP can assist companies with various support streams, including the Innovation Accelerator Programme designed to accelerate innovation and provide the right skills and tools they need when starting out.

Working in partnership with the University of Nottingham, the aim of MeTAP is to support companies to accelerate innovation and provide the right skills and tools to enable companies to increase their competitive advantage.

Medilink Midlands Innovation Advisor Caroline Sykes was joined by speakers from CHEATA, the Centre for Healthcare Technologies and companies working within the University of Nottingham itself.

For more information on MeTap, click here

For more information on the 24 May event, click here

Latest Opportunities

Volunteering opportunities through Silverstone Park Schools Programme

Now entering its seventh year, the Silverstone Park Schools Programme inspires Year 8 and 9…

College of Life & Sports Sciences Careers Expo at Birmingham City University

Businesses are invited to attend Birmingham City University’s (BCU) College of Life & Sports Sciences…

The Life Sciences Innovative Manufacturing Fund

The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to…

Latest News

Veteran Medilink Midlands retirement announcement

Officially announced today (22 November), Medilink Midlands longest serving member of staff is set to…

Clinics will provide support to budding innovators

Budding entrepreneurs can get advice on how to bring their products to life thanks to…

World-class ‘accelerator’ to speed development of crucial rehabilitation technologies

A world-class impact accelerator will connect hundreds of East Midlands MedTech SMEs with health and…